This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources.(June 2013) (Learn how and when to remove this message)
Society for Immunotherapy of Cancer (SITC)
Formation
1984
Type
Non-Profit Medical Society
Headquarters
Milwaukee, Wisconsin
Official language
English
Executive Director
Mary Dean, JD, CAE
President
Patrick Hwu, MD - Moffitt Cancer Center
Key people
Vice President: Leisha Emens, MD, PHD - UPMC Hillman Cancer Center
Secretary/Treasurer: Jedd Wolchok, MD, PhD - Memorial Sloan Kettering Cancer Center
Immediate Past President: Mario Sznol, MD - Yale School of Medicine
Website
www.sitcancer.org
The Society for Immunotherapy of Cancer (SITC), previously known as the International Society for Biological Therapy of Cancer (iSBTc), is a professional society of scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving outcomes in patients with cancer by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 2,400 members, representing 22 medical specialties from 42 countries around the world, who are engaged in the research and treatment of cancer.
Through emphasis on high-caliber scientific meetings, dedication to education and outreach activities, focus on initiatives of major importance to the field, and commitment to collaborations with like-minded organizations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community in an effort to make cancer immunotherapy one of the four standards of care and the word “cure” a reality for cancer patients living with this disease.
The goals of SITC are directed towards the rapid dissemination of information in these areas to expedite the safe transfer of both basic and applied research to the clinical setting.
and 25 Related for: Society for Immunotherapy of Cancer information
Cancerimmunotherapy (immuno-oncotherapy) is the stimulation of the immune system to treat cancer, improving the immune system's natural ability to fight...
preliminary research for its potential to treat various forms ofcancer. Cell-based immunotherapies are effective for some cancers. Immune effector cells...
therapies derived from biotechnology research, such as cancerimmunotherapy and gene therapy. Cancer research is done in academia, research institutes, and...
by 10-15% of people with CRC. Immunotherapy with immune checkpoint inhibitors has been found to be useful for a type of colorectal cancer with mismatch...
include hyperthermia, immunotherapy, photodynamic therapy, and stem-cell therapy. Most commonly cancer treatment involves a series of separate therapies...
other parts of the body. A number of types of pancreatic cancer are known. The most common, pancreatic adenocarcinoma, accounts for about 90% of cases, and...
identification of actionable genomic alterations in cancer, mechanisms of therapy resistance, clinical trials on targeted therapy, and cancerimmunotherapy research...
Member of the United States National Academy of Medicine. Fellow of the SocietyforImmunotherapyofCancer Academy of Immuno-Oncology. President of the...
include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy. Kidney cancer newly affected about 403,300 people and resulted in...
an early form ofimmunotherapy to eradicate tumors. Rose Hawthorne, daughter of author Nathaniel Hawthorne, trained there in the summer of 1896 before founding...
since 2020) SocietyforImmunotherapyofCancer, a professional societyfor advancing the science and application ofcancerimmunotherapy Standard International...
which was for many years the gold standard of chemotherapy for colorectal cancer. SurVaxM, a cancerimmunotherapy vaccine, was awarded orphan drug status...
JM (2020). "The promise and peril of targeting cell metabolism forcancer therapy". Cancer Immunology, Immunotherapy. 69 (2): 255–261. doi:10.1007/s00262-019-02432-7...
partner of the SocietyforImmunotherapyofCancer and Vaccine Confidence Project. A single evaluation is carried out through the Committee for Medicinal...
elected SocietyforImmunotherapyofCancer Inaugural Class of Fellows of the Academy of Immuno-Oncology 2023 elected president of the AACR for 2023–2024...
A. Schlipmann Melanoma Cancer Foundation. AIM is a partner of the SocietyforImmunotherapyofCancer. In the first quarter of 2021, the foundation received...
that immunotherapy is effective for ovarian cancer. However, trials of the antibody and VEGF inhibitor bevacizumab, which can slow the growth of new blood...
Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer". Cancers. 13 (3):...
Member of the Board of Directors of the SocietyforImmunotherapyofCancer 2014: Hardy Cinader Award 2011: CSI Investigator Award 2006: Fellow of the Royal...
combination of surgery, chemotherapy, radiation therapy, and targeted therapy. For certain subtypes of gastric cancer, cancerimmunotherapy is an option...
Yan H, Li MP, et al. (January 2017). "New Immunotherapy Strategies in Breast Cancer". International Journal of Environmental Research and Public Health...
Global Information